Skip to main content
Top
Published in: Cancer Causes & Control 3/2016

01-03-2016 | Brief report

Latent class model characterization of neighborhood socioeconomic status

Authors: Aimee Palumbo, Yvonne Michael, Terry Hyslop

Published in: Cancer Causes & Control | Issue 3/2016

Login to get access

Abstract

Purpose

Neighborhood-level socioeconomic status (NSES) can influence breast cancer mortality and poorer health outcomes are observed in deprived neighborhoods. Commonly used NSES indexes are difficult to interpret. Latent class models allow for alternative characterization of NSES for use in studies of cancer causes and control.

Methods

Breast cancer data was from a cohort of women diagnosed at an academic medical center in Philadelphia, PA. NSES variables were defined using Census data. Latent class modeling was used to characterize NSES.

Results

Complete data was available for 1,664 breast cancer patients diagnosed between 1994 and 2002. Two separate latent variables, each with 2-classes (LC2) best represented NSES. LC2 demonstrated strong associations with race and tumor stage and size.

Conclusions

Latent variable models identified specific characteristics associated with advantaged or disadvantaged neighborhoods, potentially improving our understanding of the impact of socioeconomic influence on breast cancer prognosis. Improved classification will enhance our ability to identify vulnerable populations and prioritize the targeting of cancer control efforts.
Appendix
Available only for authorised users
Literature
2.
go back to reference Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721–1728. http://www.ncbi.nlm.nih.gov/pubmed/17387718. Accessed 8 Nov 2013 Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721–1728. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​17387718. Accessed 8 Nov 2013
12.
go back to reference LeClere FB, Rogers RG, Peters KD (1997) Ethnicity and mortality in the United states: individual and community correlates. Soc Forces 76:169–198CrossRef LeClere FB, Rogers RG, Peters KD (1997) Ethnicity and mortality in the United states: individual and community correlates. Soc Forces 76:169–198CrossRef
20.
go back to reference Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the national cancer institute’s surveillance, epidemiology, and end results database. Cancer 110:876–884. doi:10.1002/cncr.22836 CrossRefPubMed Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the national cancer institute’s surveillance, epidemiology, and end results database. Cancer 110:876–884. doi:10.​1002/​cncr.​22836 CrossRefPubMed
23.
go back to reference Muthén LK, Muthén BO (2012) MPlus user’s guide, 7th edn. Muthén & Muthén, Los Angeles Muthén LK, Muthén BO (2012) MPlus user’s guide, 7th edn. Muthén & Muthén, Los Angeles
24.
go back to reference Muthén BO (2001) Latent variable mixture modeling. In: Marcoulides GA, Schumacker RE (eds) new developments and techniques in structural equation modeling. Lawrence Erlbaum Associates, Inc., Mahwah, pp 1–34 Muthén BO (2001) Latent variable mixture modeling. In: Marcoulides GA, Schumacker RE (eds) new developments and techniques in structural equation modeling. Lawrence Erlbaum Associates, Inc., Mahwah, pp 1–34
25.
go back to reference Nylund KL, Asparouhov T, Muthén BO (2007) Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo Simulation study. Struct Equ Model 14:535–569CrossRef Nylund KL, Asparouhov T, Muthén BO (2007) Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo Simulation study. Struct Equ Model 14:535–569CrossRef
26.
go back to reference Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New York Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New York
32.
34.
go back to reference McCutcheon AL (1987) Latent class analysis. Sage, Newbury Park McCutcheon AL (1987) Latent class analysis. Sage, Newbury Park
35.
go back to reference Gomez SL, Shariff-Marco S, DeRouen M, Keegan THM, Yen IH et al (2015) The impact of neighborhood social and built environment factors across the cancer continuum: current research, methodological considerations, and future directions. Cancer. doi:10.1002/cncr.29345 Gomez SL, Shariff-Marco S, DeRouen M, Keegan THM, Yen IH et al (2015) The impact of neighborhood social and built environment factors across the cancer continuum: current research, methodological considerations, and future directions. Cancer. doi:10.​1002/​cncr.​29345
36.
go back to reference Muthén BO (1992) latent variable modeling in epidemiology. Alcohol Health Res World 16:286–292 Muthén BO (1992) latent variable modeling in epidemiology. Alcohol Health Res World 16:286–292
Metadata
Title
Latent class model characterization of neighborhood socioeconomic status
Authors
Aimee Palumbo
Yvonne Michael
Terry Hyslop
Publication date
01-03-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 3/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0711-4

Other articles of this Issue 3/2016

Cancer Causes & Control 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine